June 12, 2017 / 11:44 AM / a month ago

BRIEF-Cardiome announces commercial launch of BRINAVESS in Canada

1 Min Read

June 12 (Reuters) - Cardiome Pharma Corp:

* Cardiome announces commercial launch of Brinavess® (vernakalant hydrochloride) in Canada

* Says product is currently available on Ontario formulary, with a broader launch anticipated in q3 of this year

* Cardiome Pharma Corp says product is currently available on Ontario formulary, with a broader launch anticipated in Q3 of 2017

* Cardiome Pharma Corp- we are ready for sales to commence ahead of our previously guided Q4 timeline. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below